A detailed history of Black Rock Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Black Rock Inc. holds 23,191,248 shares of DVAX stock, worth $278 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,191,248
Previous 23,396,930 0.88%
Holding current value
$278 Million
Previous $327 Million 12.01%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$11.7 - $14.98 $2.41 Million - $3.08 Million
-205,682 Reduced 0.88%
23,191,248 $288 Million
Q4 2023

Feb 13, 2024

BUY
$13.09 - $14.98 $28.2 Million - $32.3 Million
2,154,461 Added 10.14%
23,396,930 $327 Million
Q3 2023

Nov 13, 2023

BUY
$12.64 - $14.99 $26 Million - $30.9 Million
2,058,622 Added 10.73%
21,242,469 $314 Million
Q2 2023

Aug 11, 2023

BUY
$9.85 - $13.17 $3.03 Million - $4.05 Million
307,793 Added 1.63%
19,183,847 $248 Million
Q1 2023

May 12, 2023

SELL
$9.44 - $11.88 $1.99 Million - $2.5 Million
-210,409 Reduced 1.1%
18,876,054 $185 Million
Q4 2022

Feb 13, 2023

BUY
$10.27 - $13.29 $5.97 Million - $7.72 Million
581,175 Added 3.14%
19,086,463 $203 Million
Q3 2022

Nov 14, 2022

SELL
$9.93 - $17.44 $562,097 - $987,208
-56,606 Reduced 0.3%
18,505,288 $193 Million
Q2 2022

Aug 12, 2022

BUY
$7.45 - $12.83 $80.2 Million - $138 Million
10,767,432 Added 138.14%
18,561,894 $234 Million
Q1 2022

May 12, 2022

SELL
$9.75 - $14.44 $720,154 - $1.07 Million
-73,862 Reduced 0.94%
7,794,462 $84.5 Million
Q4 2021

Feb 10, 2022

SELL
$13.17 - $20.94 $888,751 - $1.41 Million
-67,483 Reduced 0.85%
7,868,324 $111 Million
Q3 2021

Nov 09, 2021

SELL
$9.16 - $19.83 $3.38 Million - $7.32 Million
-369,047 Reduced 4.44%
7,935,807 $152 Million
Q2 2021

Aug 11, 2021

BUY
$7.25 - $10.99 $60.2 Million - $91.3 Million
8,304,854 New
8,304,854 $81.8 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.52B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.